These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2940132)

  • 1. Mechanism-based proteinase inhibitors: a critical review.
    Walker B
    Biochem Soc Trans; 1986 Apr; 14(2):397-9. PubMed ID: 2940132
    [No Abstract]   [Full Text] [Related]  

  • 2. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
    Lijnen HR; Uytterhoeven M; Collen D
    Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.
    Kettner C; Shaw E
    Methods Enzymol; 1981; 80 Pt C():826-42. PubMed ID: 6210829
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
    Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
    J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride selectively inhibits the urokinase-type plasminogen activator.
    Vassalli JD; Belin D
    FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA; Anderson JA; Bennett B
    Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.
    Osterwalder T; Cinelli P; Baici A; Pennella A; Krueger SR; Schrimpf SP; Meins M; Sonderegger P
    J Biol Chem; 1998 Jan; 273(4):2312-21. PubMed ID: 9442076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of plasminogen activator associated with chronic granulomatous inflammation.
    Goldstein SM; Izaki S; Epstein WL
    Thromb Res; 1979; 16(5-6):727-35. PubMed ID: 160627
    [No Abstract]   [Full Text] [Related]  

  • 10. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
    Reboud-Ravaux M; Vilain AC; Boggetto N; Maillard J; Favreau C; Xie J; Mazaleyrat JP; Wakselman M
    Biochem Biophys Res Commun; 1991 Jul; 178(1):352-9. PubMed ID: 1829886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.
    Coleman P; Kettner C; Shaw E
    Biochim Biophys Acta; 1979 Jul; 569(1):41-51. PubMed ID: 111716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
    Badenoch-Jones P; Ramshaw IA; Grant A
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking of the fibrinolytic antiactivator by substituted benzoates.
    Nanninga L; Guest M
    Life Sci; 1974 Jun; 14(12):2507-11. PubMed ID: 4283613
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
    Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
    Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of a partially purified preparation of a circulating plasminogen activator.
    Ogston D; Bennett B; Mackie M
    Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification of epidermal plasminogen activator inhibitor.
    Hibino T; Izaki S; Izaki M
    FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.
    Mor A; Maillard J; Favreau C; Reboud-Ravaux M
    Biochim Biophys Acta; 1990 Mar; 1038(1):119-24. PubMed ID: 2138500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.